// App-Quantinova.ai

2067 : Pneumococcal Bacteremia Among Patients with Hematological Malignancies: Clinical Impact, Serotype Distribution and Antibiotic Resistance Profile in Tertiary-Care Centers

Researchers

Presenter

  • Shi Hann Su

Principal Investigators

  • Sylvie Belanger

  • Brigitte Lefebvre

  • Valery Lavergne

  • Sandra Cohen

  • Annie-Claude Labbe

Medical Centers

  • Department of microbiology, Sacre-Coeur de Montreal Hospital, Montreal, QC, Canada

  • Hematology resident, University of Montreal, Montreal, QC, Canada

  • Department of microbiology, Hopital Notre-Dame du CHUM, Montreal, QC, Canada

  • Laboratoire de sante publique du Quebec / Institut national de sante publique du Quebec, Ste-Anne-de-Bellevue, QC, Canada

  • Department of Hematology, Hopital Maisonneuve Rosemont, Montreal, Canada

  • Research Center, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

  • hematology-Oncology, Hopital Maisonneuve-Roseont, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Graft-versus-host disease

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Pneumococcal polysaccharide vaccine

  • Pneumococcal Conjugate Vaccine

  • Trimethoprim/sulfamethoxazole

  • Fluoroquinolone

  • Erythromycin

  • E.E.S. 400 Oral

  • Trimethoprim

  • ceftriaxone

  • Pentamidine

  • NebuPent

  • Penicillin

  • Benzylpenicillin

  • vancomycin capsule

  • 13-valent pneumococcal conjugate vaccine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved